Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of moderate to severe HS for at least 6 months prior to Baseline as determined by the investigator (i.e., through medical history and interview of participant).
Total abscess and inflammatory nodule (AN) count of ≥ 5 at Baseline
Hidradenitis suppurativa (HS) lesions present in at least two distinct anatomic areas at Baseline.
At least 1 anatomic area of HS involvement characterized as Hurley Stage II or higher at Baseline.
You may not be if
Any evidence of Hepatitis B virus (HBV) or hepatitis C virus (HCV) infection.
Evidence of active tuberculosis or meets tuberculosis exclusionary parameter
Clareo Health | A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
